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Viral, bacterial, and parasitic infections comprise a vast group
of etiological agents that cause acute or chronic diseases.
According to WHO, they represent one of the major causes
of human morbidity and mortality. AIDS, lower respiratory
tract infections, and diarrheal diseases underlie up to 5
million deaths each year, especially in the middle- and low-
income countries. Some of the infections causing chronic dis-
ease lead to the development of an array of deadly pathologies
including cancer, autoimmune diseases, diabetes mellitus,
and malfunctions of various organs. During the last two
decades it has been clearly established that many of these
infections trigger the production of reactive oxygen (ROS)
and nitrogen (RNS) species.This is particularly true for infec-
tions caused by the blood-borne hepatitis viruses (B, C,
and D), human immunodeficiency virus (HIV), influenza
A, Epstein-Barr virus, respiratory syncytial virus, and other
viruses. For acute respiratory viral infections, ROS/RNS have
been implicated in lung tissue injury and epithelial barrier
dysfunction which in turn increased the susceptibility to sec-
ondary infections. In case of chronic viral hepatitis, oxidative
stress was shown to promote liver fibrosis, cirrhosis, and can-
cer, as well as metabolic dysfunction. HIV-induced oxidative
stress was shown to contribute to neurodegenerative compli-
cations which are often observed in AIDS patients. Last but
not least, a virus-induced oxidative burst has been recently
associated with the development of the acute childhood lym-
phoblastic leukemia. In bacterial infections oxidative stress
arises, at least in part, from altered metabolic pathways and
has also been implicated in organ damage and the devel-
opment of malignancies. Helicobacter pylori, for example,
induces ROS-generating enzymes such as spermine oxi-
dase and upregulates proinflammatory and procancerogenic
redox-regulated genes like cyclooxygenase 2. Despite the
overwhelming evidence of the role of oxidative stress in acute
and chronic infection and the associated diseases, the impact
of the majority of infectious agents on the host redox systems
is not sufficiently characterized, with published data plagued
by the controversies.
The current special issue aims to bring together both
research papers and review articles on the mechanisms by
which viral and bacterial infections trigger ROS production
and induce and modulate the antioxidant defense systems
and papers on the role of reactive oxygen species in viral
propagation and infection-associated pathologies. We have
also invited manuscripts from other fields of redox biology
in order to bring new perspectives to the studies of oxidative
stress in infections and consequent disease.
Contributed manuscripts emphasize the heavy impact
of oxidative stress on the pathogenesis of viral infections.
Two independent reviews discuss oxidative stress in chronic
infection with hepatitis C virus (HCV). The review by R.
Medvedev et al. scrutinizes multiple mechanisms by which
HCV enhances ROS production providing at the same time
an in-depth analysis of viral influence on the protective Nrf2
pathway. Special attention is paid to the redox-regulated
events by which HCV triggers autophagy such as ER stress
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and the unfolded protein response. A concise review article
of K. Rebbani and K. Tsukiyama-Kohara focuses on ROS-
sensitive mechanisms of HCV-induced hepatocarcinogene-
sis. In particular, this review discusses the cholesterol biosyn-
thesis enzyme 3𝛽-hydroxysterol Δ24-reductase (DHCR24),
induced byHCVand recognized as a hostmarker of oxidative
stress, as biomarker for the prognosis of hepatocellular carci-
noma. These reviews are complemented by a research paper
by O. A. Smirnova et al. on the mechanisms of induction of
oxidative stress by a component of HCV replication complex
nonstructural protein NS5A. Earlier NS5A was thought to
induce oxidative stress by altering calcium homeostasis [1].
In contrast to this, O. A. Smirnova et al. found that NS5A
contributes to ROS production by activating expression of
NADPH oxidases 1 and 4 as well as cytochrome P450 2E1.
NOX1 and NOX4 induction was mediated by enhanced
production of transforming growth factor 𝛽1. Earlier similar
results were obtained by us for HCV core protein [2]. This
perfectly exemplified the capacity of the virus to induce
oxidative stress by several multistep mechanisms.
One review and an experimental manuscript deal with
oxidative stress in HIV infection. A review by the editors of
this issue summarizes the data on the oxidative stressmarkers
associated in HIV infection, analyzes mechanisms by which
this virus triggers massive ROS production, and scrutinizes
the scarce data that exist on the effect of ROS on HIV-1 repli-
cation.The review presents the current state of knowledge on
the redox alterations as crucial factors ofHIV-1 pathogenicity,
namely, neurotoxicity, dementia, and T-cell exhaustion, as
well as certain side effects of the antiretroviral therapy, in
comparison to the pathologies associated with the nitrosative
stress. A thorough experimental work by X. Huang et al. ana-
lyzes the status of oxidative stress in HIV/HCV coinfection
delineating the contribution of HIV to HCV-induced liver
damage. The study also discusses correlations between liver
pathology and level of oxidative stress inHIV/HCV-coinfect-
ed patients, as well as the capacity of HIV infection to accel-
erate HCV-associated liver damage in HIV/HCV-coinfected
individuals.
Not only RNA, but also a variety of DNA viruses are
associated with the increased oxidative stress promoting
DNA damage, high mutagenicity, and initiation and/or pro-
gression of neoplasia [3]. A review article by M. Mushtaq et
al. summarizes current knowledge on the metabolic distur-
bances induced by DNA viruses, many of which are achieved
through the redox-sensitive processes. This review focuses
on the enhanced consumption of glucose, its conversion into
pyruvate (glycolysis), and the switch to lactate formation,
characteristic for cells transformed with tumor DNA viruses.
Under physiological conditions, one glucosemolecule is con-





results in synthesis of 38 ATP molecules. At low
oxygen concentrations, pyruvate is not oxidized but instead
converted to lactate; this process still produces ATP but is
independent of O
2
and can occur under hypoxic conditions.
Glucose is not only important for ATP production, but also
used by the pentose phosphate pathway to produce nucleic
acids and NADPH which in turn required to neutralize ROS.
Cancer cells increase frequently glucose uptake and lactate
production, which are features of the Warburg effect [4, 5].
The review by M. Mushtaq et al. summarizes evidence that
shows that not only tumor DNA viruses, but also single
viral proteins can enhance glucose uptake and control the
tumormicroenvironment, thus promoting tumor growth and
metastasis.
While six papers of the special issue deal with the oxida-
tive stress and consequent disease caused by viral infections,
G. S. Krasnov et al. uncover the changes in transcriptome in
the tumor tissues from patients with colorectal cancer associ-
atedwith infectionwithBacteroides fragilis.This study reveals
a significant induction of a number of enzymes involved
in the biosynthesis and degradation of biogenic polyamines
including spermine oxidase (SMO). SMO converts spermine




and acrolein as by-
products [6]. Earlier studies associated this enzyme with the
development of gastrointestinal tumors in patients infected
with both Bacteroides fragilis [7] and Helicobacter pylori
[8]. We believe that such a modulation of the polyamine
metabolism is also highly relevant to viral infections. Indeed,
we have recently shown similar induction of SMObyhepatitis
C virus and its proteins [9]. However, the impact of changes
to the polyamine metabolism on the physiopathology associ-
ated with viral infections remains to be studied.
Autoimmune arthritis can be induced experimentally;
however, in humandisease, both viral and bacterial infectious
agents have been extensively discussed as triggers [10–12].
In this special issue, one paper deals with autoimmune
arthritis, albeit induced by an experimental immunization. A.
A.Andreev-Andrievskiy et al. present the evidence of promis-
ing therapeutic activity of the mitochondrially targeted
antioxidant SkQ against rheumatoid arthritis experimentally
induced by immunizing rats with collagen. In our view, a
treatment approach based on the usage of antioxidants could
be applied to prevent infection-associated pathologies and
deserves experimental testing in the relevant animal models
of human infections.
Finally, a very interesting paper of V. A. Mitkevich et
al. discusses glutathionylation of Na,K-ATPase. The paper
shows that this redox-sensitive posttranslational modifica-
tion is promoted by hypoxia, an event accompanied by a
severe oxidative stress. The authors provide evidence that the
glutathione residues are shielding by the protein inside the
protein globule.This paper, even though it does not deal with
an infectious agent, may be mechanistically highly applicable
to future studies in redox biology of human pathogens. To our
knowledge, there is almost no published data on the redox-
sensitive modifications of bacterial or viral proteins, with the
exception of HIV protease.
We hope that this issue will help to deepen our under-
standing of the role of redox homeostasis in the pathologies
associated with human infection by drawing attention to
the novel aspects of redox control, such as the polyamine
metabolism, glutathionylation, and novel therapies based on
the use of antioxidants.
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